More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$250892351
EPS
-1.12
P/E ratio
--
Price to sales
0.3
Dividend yield
--
Beta
0.6569
Previous close
$13.54
Today's open
$13.32
Day's range
$13.25 - $13.73
52 week range
$12.53 - $23.59
show more
CEO
Kevin Guest
Employees
1570
Headquarters
Salt Lake City, UT
Exchange
New York Stock Exchange
Shares outstanding
18488751
Issue type
Common Stock
Consumer Staples
Consumer Products - Healthcare
USANA Health Sciences Q3 Earnings Call Highlights
USANA Health Sciences NYSE: USNA expects 2026 net sales approaching $900 million and adjusted EBITDA of approximately $77 million, down from its prior adjusted EBITDA outlook of $80.5 million, as weaker sales at Rise Wellness and increased marketing investment at Hiya offset stronger profitability in its core nutrition business.
MarketBeat • Nov 7, 2026

USANA Health Sciences, Inc. (USNA) Q3 2026 Earnings Call Transcript
USANA Health Sciences, Inc. ( USNA ) Q3 2026 Earnings Call November 4, 2026 11:00 AM EST Company Participants Andrew Masuda - Director of Investor Relations Kevin Guest - CEO & Executive Chairman G. Hekking - Chief Financial Officer Brent Neidig - Chief Commercial Officer Kathryn Armstrong - Chief Scientific Officer Walter Noot - Chief Operating Officer Conference Call Participants Anthony Lebiedzinski - Sidoti & Company, LLC Presentation Operator Greetings, and welcome to the USANA Health Sciences Third Quarter Earnings Conference Call.
Seeking Alpha • Nov 4, 2026

USANA Health Sciences Reports Third Quarter 2026 Results
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended October 3, 2026. Key Financial Results Third Quarter 2026 vs. Third Quarter 2025 Net sales of $206 million versus $214 million. Net loss of $(5.6) million versus $(6.5) million. Diluted EPS of $(0.30) as compared with $(0.36). Adjusted diluted EPS(1) of $(0.11) as compared with $(0.15). Adjusted EBITDA(2) of $12.1 million versus $13.8 million. Core Nutri.
Business Wire • Nov 3, 2026

USANA Health Sciences (USNA) Reports Q3 Loss, Lags Revenue Estimates
USANA Health Sciences (USNA) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.11. This compares to a loss of $0.15 per share a year ago.
Zacks Investment Research • Nov 3, 2026

USANA BiOmega Earns ConsumerLab Seal of Approval for Quality and Purity
Independent testing provides third-party validation of USANA's commitment to product quality and label accuracy SALT LAKE CITY, Nov. 3, 2026 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA), a global leader in cellular nutrition, announced that its BiOmega omega-3 supplement has once again earned the ConsumerLab Seal of Approval, providing independent validation of the company's longstanding commitment to product quality, purity and label accuracy. USANA voluntarily submitted BiOmega to ConsumerLab's Quality Certification Program, where it underwent the same testing applied to omega-3 products independently selected by ConsumerLab for its 2026 Fish Oil, Krill Oil, and Algal Oil Omega-3 Supplements Review.
PRNewsWire • Nov 3, 2026

As Thanksgiving Nears, USANA CEO Kevin Guest Urges All to Rethink What Success Really Means
Author and business leader encourages gratitude for experiences, relationships, lessons that make life meaningful SALT LAKE CITY, Nov. 2, 2026 /PRNewswire/ -- As millions of people prepare to reconnect with family and friends during the Thanksgiving holiday season, USANA Health Sciences (NYSE: USNA) Chairman and CEO Kevin Guest is encouraging people to reconsider how they measure success. Rather than focusing solely on income, career achievements or material possessions, Guest suggests looking at the experiences, relationships and lessons that have shaped their lives.
PRNewsWire • Nov 2, 2026

USANA Schedules Third Quarter 2026 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2026 results will be released after the close of market on Tuesday, November 3, 2026. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and insti.
Business Wire • Oct 12, 2026

USANA Health Sciences and University of Utah Athletics Announce New Partnership
Utah-based organizations unite to support more than 500 student-athletes across 19 sports SALT LAKE CITY, Oct. 7, 2026 /PRNewswire/ -- USANA Health Sciences and University of Utah Athletics have announced a new partnership bringing together two Utah organizations with a shared commitment to health, performance, and excellence. Through the partnership, USANA will support more than 500 University of Utah student-athletes across 19 sports, significantly expanding the company's global roster of sponsored, elite athletes and teams.
PRNewsWire • Oct 7, 2026

USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day
SALT LAKE CITY, Oct. 1, 2026 /PRNewswire/ -- In recognition of International Music Day on Oct. 1, USANA Health Sciences (NYSE: USNA) Chairman and CEO Kevin Guest is urging people to experience music as a force that can reduce stress, lift spirits and connect people across cultures. International Music Day celebrates the world's diverse musical traditions and music's ability to advance peace, friendship, and mutual appreciation.
PRNewsWire • Oct 1, 2026

Implied Volatility Surging for USANA Health Stock Options
Investors need to pay close attention to USNA stock based on the movements in the options market lately.
Zacks Investment Research • Sep 14, 2026

¹ Disclosures

Open an M1 investment account to buy and sell USANA Health Sciences Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.